www.fdanews.com/articles/119910-cambrex-receives-fda-warning-letter
Cambrex Receives FDA Warning Letter
August 25, 2009
Cambrex Corporation announced that it has received a warning letter from the U.S. Food and Drug Administration relating to an inspection of the company’s generic active pharmaceutical ingredient manufacturing facility located in Milan, Italy in March 2009.
StreetInsider.com
StreetInsider.com